Dermatomyositis and malignancy: a retrospective study of 115 cases

被引:1
|
作者
Zhang, Wei [1 ]
Jiang, Shan-Ping [1 ]
Huang, Liwen [1 ]
机构
[1] Sun Yat Sen Univ, Dept Resp Med, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China
关键词
Dermatomyositis; Malignancy; Nasopharyngeal cancer; Lung cancer; NASOPHARYNGEAL CARCINOMA; POLYMYOSITIS; CANCER; RISK;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim of this study was to identify the association between dermatomyositis and malignancy in China. Methods: We retrospectively analyzed the clinical data of 115 cases of dermatomyositis associated with malignancy. Results: From 1974 to 2008, there were 678 cases of dermatomyositis collected from the Second Affiliated Hospital, Sun Yat-Sen University, China. Among them, 115 cases (17.0%) were associated with malignancy. 7.4% (22/297) of patients under 40 years old were diagnosed with malignant tumor, while 24.4% (93/381) of patients aged 40 years or above were associated with malignancy. Malignancy preceded dermatomyositis in 14 cases. Dermatomyositis and malignancy were diagnosed at the same time in 22 patients. Another 79 patients were found to have cancer within 3 years after the dermatomyositis was diagnosed. Among them, cancer was detected in 66 patients in the first year, 11 patients in the second year and only 2 patients in the third year. Nasopharyngeal cancer made up 51.3% (59/115) of the associated malignancies, while lung cancer accounted for 17.4% (20/115). Other malignancies associated with dermatomyositis included liver cancer, ovarian cancer, cervical lymph node metastases of unknown origin, cholangial cancer, esophageal cancer, colon cancer, laryngeal cancer, renal cancer, tongue cancer and lymphoma. Conclusions. Dermatomyositis associated with malignancy was more common in patients aged 40 years or above. Malignancy was often detected within the first year after the onset of dermatomyositis. The most common malignancy associated with dermatomyositis was nasopharyngeal cancer, followed by lung cancer in Guangdong, China.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 50 条
  • [21] Dermatomyositis and malignancy
    Hu, Tina
    Vinik, Ophir
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (06) : 409 - 411
  • [22] Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
    Marzecka, Milena
    Niemczyk, Anna
    Rudnicka, Lidia
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 63 (02) : 289 - 296
  • [23] Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis
    Kundrick, Avery
    Kirby, Joslyn
    Ba, Djibril
    Leslie, Douglas
    Olsen, Nancy
    Foulke, Galen
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (01) : 140 - 144
  • [24] Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis
    Chen, He
    Peng, Qinglin
    Yang, Hanbo
    Yin, Liguo
    Shi, Jingli
    Zhang, Yamei
    Wang, Guochun
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (06) : 835 - 840
  • [25] Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study
    Chen, YJ
    Wu, CY
    Shen, JL
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) : 825 - 831
  • [26] Two cases of dermatomyositis associated with neuroendocrine tumors
    Shani, Uria
    Lavine, Noy
    Houri-Levi, Esther
    Watad, Abdalla
    Amital, Howard
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2023, 13 (1) : 17 - 21
  • [27] Risk of Malignancy in Dermatomyositis and Polymyositis: A Systematic Review and Meta-Analysis
    Qiang, Judy K.
    Kim, Whan B.
    Baibergenova, Akerke
    Alhusayen, Raed
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2017, 21 (02) : 131 - 136
  • [28] Malignancy in dermatomyositis and polymyositis: analysis of 192 patients
    Fang, Yao-Fan
    Wu, Yeong-Jian Jan
    Kuo, Chang-Fu
    Luo, Shue-Fen
    Yu, Kuang-Hui
    CLINICAL RHEUMATOLOGY, 2016, 35 (08) : 1977 - 1984
  • [29] Malignancy in dermatomyositis and polymyositis: analysis of 192 patients
    Yao-Fan Fang
    Yeong-Jian Jan Wu
    Chang-Fu Kuo
    Shue-Fen Luo
    Kuang-Hui Yu
    Clinical Rheumatology, 2016, 35 : 1977 - 1984
  • [30] Evidence supports blind screening for internal malignancy in dermatomyositis Data from 2 large US dermatology cohorts
    Leatham, Hayley
    Schadt, Courtney
    Chisolm, Sarah
    Fretwell, Deborah
    Chung, Lorinda
    Callen, Jeffrey P.
    Fiorentino, David
    MEDICINE, 2018, 97 (02)